Last reviewed · How we verify
Lactulose oral solution — Competitive Intelligence Brief
marketed
Osmotic laxative / Prebiotic
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Lactulose oral solution (Lactulose oral solution) — Peking Union Medical College Hospital. Lactulose is a non-absorbable disaccharide that draws water into the colon and is metabolized by colonic bacteria to produce organic acids, lowering pH and promoting bowel movements.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lactulose oral solution TARGET | Lactulose oral solution | Peking Union Medical College Hospital | marketed | Osmotic laxative / Prebiotic |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Osmotic laxative / Prebiotic class)
- Peking Union Medical College Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lactulose oral solution CI watch — RSS
- Lactulose oral solution CI watch — Atom
- Lactulose oral solution CI watch — JSON
- Lactulose oral solution alone — RSS
- Whole Osmotic laxative / Prebiotic class — RSS
Cite this brief
Drug Landscape (2026). Lactulose oral solution — Competitive Intelligence Brief. https://druglandscape.com/ci/lactulose-oral-solution. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab